NasdaqGS:AMRXPharmaceuticals
Amneal Pharmaceuticals (AMRX) Stock May Be Fully Priced Following Its 4.7x Run
Amneal Pharmaceuticals has turned in a very strong share price run over the last few years, yet its valuation checks lean expensive rather than cheap, which raises the question of how much of that strength is already reflected in the current price.
Over the last three years the stock has returned about 4.7x, which sets a high bar for any further gains to be justified by business progress.
The recent U.S. FDA approval that expands Amneal Pharmaceuticals' iohexol injection portfolio can...